These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 22034039)

  • 1. Production and purification of recombinant adeno-associated vectors.
    Wang L; Blouin V; Brument N; Bello-Roufai M; Francois A
    Methods Mol Biol; 2011; 807():361-404. PubMed ID: 22034039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
    Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
    Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scaleable chromatographic purification process for recombinant adeno-associated virus (rAAV).
    O'Riordan CR; Lachapelle AL; Vincent KA; Wadsworth SC
    J Gene Med; 2000; 2(6):444-54. PubMed ID: 11199265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications.
    Grieger JC; Samulski RJ
    Adv Biochem Eng Biotechnol; 2005; 99():119-45. PubMed ID: 16568890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus.
    Liu XL; Clark KR; Johnson PR
    Gene Ther; 1999 Feb; 6(2):293-9. PubMed ID: 10435114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpesvirus-based infectious titering of recombinant adeno-associated viral vectors.
    Mohiuddin I; Loiler S; Zolotukhin I; Byrne BJ; Flotte TR; Snyder RO
    Mol Ther; 2005 Feb; 11(2):320-6. PubMed ID: 15668144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of recombinant adeno-associated virus type 8 vectors by ion exchange chromatography generates clinical grade vector stock.
    Davidoff AM; Ng CY; Sleep S; Gray J; Azam S; Zhao Y; McIntosh JH; Karimipoor M; Nathwani AC
    J Virol Methods; 2004 Nov; 121(2):209-15. PubMed ID: 15381358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recombinant adeno-associated virus vector related impurities].
    Diao Y; Wang Q; Xiao W; Xu R
    Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):717-23. PubMed ID: 21845838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of recombinant adeno-associated virus vectors.
    Zolotukhin S
    Hum Gene Ther; 2005 May; 16(5):551-7. PubMed ID: 15916480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids.
    Booth MJ; Mistry A; Li X; Thrasher A; Coffin RS
    Gene Ther; 2004 May; 11(10):829-37. PubMed ID: 14985784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adeno-associated virus vectorology, manufacturing, and clinical applications.
    Grieger JC; Samulski RJ
    Methods Enzymol; 2012; 507():229-54. PubMed ID: 22365777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adeno-associated viruses.
    Mezzina M; Merten OW
    Methods Mol Biol; 2011; 737():211-34. PubMed ID: 21590399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromatographic purification of recombinant adenoviral and adeno-associated viral vectors: methods and implications.
    Burova E; Ioffe E
    Gene Ther; 2005 Oct; 12 Suppl 1():S5-17. PubMed ID: 16231055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An efficient rHSV-based complementation system for the production of multiple rAAV vector serotypes.
    Kang W; Wang L; Harrell H; Liu J; Thomas DL; Mayfield TL; Scotti MM; Ye GJ; Veres G; Knop DR
    Gene Ther; 2009 Feb; 16(2):229-39. PubMed ID: 18923452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and characterization of adeno-associated viral vectors.
    Grieger JC; Choi VW; Samulski RJ
    Nat Protoc; 2006; 1(3):1412-28. PubMed ID: 17406430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector.
    Grieger JC; Soltys SM; Samulski RJ
    Mol Ther; 2016 Feb; 24(2):287-297. PubMed ID: 26437810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scalable serum-free production of recombinant adeno-associated virus type 2 by transfection of 293 suspension cells.
    Durocher Y; Pham PL; St-Laurent G; Jacob D; Cass B; Chahal P; Lau CJ; Nalbantoglu J; Kamen A
    J Virol Methods; 2007 Sep; 144(1-2):32-40. PubMed ID: 17467815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. rAAV vector product characterization and stability studies.
    Snyder RO; Audit M; Francis JD
    Methods Mol Biol; 2011; 807():405-28. PubMed ID: 22034040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adeno-associated virus serotypes: vector toolkit for human gene therapy.
    Wu Z; Asokan A; Samulski RJ
    Mol Ther; 2006 Sep; 14(3):316-27. PubMed ID: 16824801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current issues in adeno-associated viral vector production.
    Merten OW; Gény-Fiamma C; Douar AM
    Gene Ther; 2005 Oct; 12 Suppl 1():S51-61. PubMed ID: 16231056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.